Cochlear Limited (OC5)
Market Closed
8 Dec, 20:00
XBER 
€
154. 22
+2.4
+1.58%
€
- Market Cap
- P/E Ratio
5.86% Div Yield
0 Volume
- Eps
€ 151.82
Previous Close Day Range
154.22 154.22
Year Range
134.46 190.24
Want to track OC5 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 64 days
Summary
OC5 closed today higher at €154.22, an increase of 1.58% from yesterday's close, completing a monthly decrease of -0.23% or €0.36. Over the past 12 months, OC5 stock lost -11.46%.
OC5 pays dividends to its shareholders, with the most recent payment made on Oct 13, 2025. The next estimated payment will be in In 4 months on Apr 13, 2026 for a total of €2.15.
The last earnings report, released on Aug 13, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Feb 11, 2026.
The stock of the company had never split.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on ASX (AUD).
OC5 Chart
Cochlear Limited (OC5) FAQ
What is the stock price today?
The current price is €154.22.
On which exchange is it traded?
Cochlear Limited is listed on ASX.
What is its stock symbol?
The ticker symbol is OC5.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 5.86%.
What is its market cap?
As of today, no market cap data is available.
When is the next earnings date?
The next earnings report will release on Feb 11, 2026.
Has Cochlear Limited ever had a stock split?
No, there has never been a stock split.
Cochlear Limited Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Mr. Diggory William Howitt BE (Hons), MBA CEO | XBER Exchange | AU000000COH5 ISIN |
| AU Country | 4,996 Employees | 18 Sep 2025 Last Dividend | - Last Split | - IPO Date |
Overview
Cochlear Limited, established in 1981 and headquartered in Sydney, Australia, is a global leader in providing implantable hearing solutions. It is dedicated to helping children and adults worldwide to overcome hearing loss through innovative technologies. The company takes pride in its extensive history of advancing the field of auditory health, offering a range of products that enhance the ability to hear and communicate effectively.
Products and Services
- Cochlear Implant Systems: These systems are designed to mimic natural hearing and provide a solution for individuals with severe to profound nerve deafness. They work by directly stimulating the cochlea's nerve fibers, bypassing damaged parts of the ear.
- Sound Processor Upgrades: Cochlear offers advanced sound processors that are compatible with its implant systems. These upgrades are designed to improve sound quality, offer new features, and ensure users have access to the latest technology in hearing solutions.
- Bone Conduction Systems: For individuals with conductive hearing loss, mixed hearing loss, or single-sided deafness, Cochlear's bone conduction systems transmit sound through the skull bone directly to the inner ear. This innovative approach offers an alternative to traditional hearing aids by providing clearer sound quality under various conditions.
- Accessories: To enhance the user experience, Cochlear provides a wide range of accessories for its devices. These include wireless streaming devices, waterproof cases, and remote controls, among others. Each accessory is designed to make daily use more convenient and to help users customize their hearing experience.
Beyond the core offerings, Cochlear continuously innovates to include new products and services that address the broader needs of the hearing-impaired community. This commitment to innovation ensures that users have access to the most advanced solutions available.
Contact Information
Address: 1 University Avenue
Phone: 61 2 9428 6555
Website: https://www.cochlear.com
2025 © Marketlog. All Rights Reserved.
